Global Medical Marijuana Market Overview And Scope:
Global Medical Marijuana Market Size was estimated at USD 4966.98 million in 2022 and is projected to reach USD 18089.26 million by 2028, exhibiting a CAGR of 24.04% during the forecast period.
The Global Medical Marijuana Market Report 2025 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Medical Marijuana utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2025 and 2032. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
Top Key Players Mentioned Are: Scotts Miracle-Gro, Canopy Growth, GW Pharmaceuticals, Aurora Cannabis, Aphria, MedReLeaf, Insys Therapeutics, Sprott, CanniMed Therapeutics, Horizons Marijuana Life Sciences Index ETF
Global Medical Marijuana Market Segmentation
By Type, Medical Marijuana market has been segmented into:Dried Flower
Oils + Concentrates
Softgel Capsules
By Application, Medical Marijuana market has been segmented into:
Muscle Spasms
Nausea (from cancer chemotherapy)
Chronic Illness (HIV/Nerve Pain)
Seizure Disorders
Crohn's Disease
Regional Analysis:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Medical Marijuana market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Medical Marijuana market.
Top Key Players Covered in Medical Marijuana market are:
Scotts Miracle-Gro
Canopy Growth
GW Pharmaceuticals
Aurora Cannabis
Aphria
MedReLeaf
Insys Therapeutics
Sprott
CanniMed Therapeutics
Horizons Marijuana Life Sciences Index ETF
Objective to buy this Report:
1. Medical Marijuana analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with Medical Marijuana market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Medical Marijuana Market by Type
5.1 Medical Marijuana Market Overview Snapshot and Growth Engine
5.2 Medical Marijuana Market Overview
5.3 Dried Flower
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Dried Flower: Geographic Segmentation
5.4 Oils + Concentrates
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Oils + Concentrates: Geographic Segmentation
5.5 Softgel Capsules
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Softgel Capsules: Geographic Segmentation
Chapter 6: Medical Marijuana Market by Application
6.1 Medical Marijuana Market Overview Snapshot and Growth Engine
6.2 Medical Marijuana Market Overview
6.3 Muscle Spasms
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Muscle Spasms: Geographic Segmentation
6.4 Nausea (from cancer chemotherapy)
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Nausea (from cancer chemotherapy): Geographic Segmentation
6.5 Chronic Illness (HIV/Nerve Pain)
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Chronic Illness (HIV/Nerve Pain): Geographic Segmentation
6.6 Seizure Disorders
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size (2017-2032F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Seizure Disorders: Geographic Segmentation
6.7 Crohn's Disease
6.7.1 Introduction and Market Overview
6.7.2 Historic and Forecasted Market Size (2017-2032F)
6.7.3 Key Market Trends, Growth Factors and Opportunities
6.7.4 Crohn's Disease: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Medical Marijuana Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Medical Marijuana Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Medical Marijuana Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 SCOTTS MIRACLE-GRO
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 CANOPY GROWTH
7.4 GW PHARMACEUTICALS
7.5 AURORA CANNABIS
7.6 APHRIA
7.7 MEDRELEAF
7.8 INSYS THERAPEUTICS
7.9 SPROTT
7.10 CANNIMED THERAPEUTICS
7.11 HORIZONS MARIJUANA LIFE SCIENCES INDEX ETF
Chapter 8: Global Medical Marijuana Market Analysis, Insights and Forecast, 2017-2032
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Dried Flower
8.2.2 Oils + Concentrates
8.2.3 Softgel Capsules
8.3 Historic and Forecasted Market Size By Application
8.3.1 Muscle Spasms
8.3.2 Nausea (from cancer chemotherapy)
8.3.3 Chronic Illness (HIV/Nerve Pain)
8.3.4 Seizure Disorders
8.3.5 Crohn's Disease
Chapter 9: North America Medical Marijuana Market Analysis, Insights and Forecast, 2017-2032
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Dried Flower
9.4.2 Oils + Concentrates
9.4.3 Softgel Capsules
9.5 Historic and Forecasted Market Size By Application
9.5.1 Muscle Spasms
9.5.2 Nausea (from cancer chemotherapy)
9.5.3 Chronic Illness (HIV/Nerve Pain)
9.5.4 Seizure Disorders
9.5.5 Crohn's Disease
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Medical Marijuana Market Analysis, Insights and Forecast, 2017-2032
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Dried Flower
10.4.2 Oils + Concentrates
10.4.3 Softgel Capsules
10.5 Historic and Forecasted Market Size By Application
10.5.1 Muscle Spasms
10.5.2 Nausea (from cancer chemotherapy)
10.5.3 Chronic Illness (HIV/Nerve Pain)
10.5.4 Seizure Disorders
10.5.5 Crohn's Disease
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Medical Marijuana Market Analysis, Insights and Forecast, 2017-2032
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Dried Flower
11.4.2 Oils + Concentrates
11.4.3 Softgel Capsules
11.5 Historic and Forecasted Market Size By Application
11.5.1 Muscle Spasms
11.5.2 Nausea (from cancer chemotherapy)
11.5.3 Chronic Illness (HIV/Nerve Pain)
11.5.4 Seizure Disorders
11.5.5 Crohn's Disease
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Medical Marijuana Market Analysis, Insights and Forecast, 2017-2032
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Dried Flower
12.4.2 Oils + Concentrates
12.4.3 Softgel Capsules
12.5 Historic and Forecasted Market Size By Application
12.5.1 Muscle Spasms
12.5.2 Nausea (from cancer chemotherapy)
12.5.3 Chronic Illness (HIV/Nerve Pain)
12.5.4 Seizure Disorders
12.5.5 Crohn's Disease
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Medical Marijuana Market Analysis, Insights and Forecast, 2017-2032
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Dried Flower
13.4.2 Oils + Concentrates
13.4.3 Softgel Capsules
13.5 Historic and Forecasted Market Size By Application
13.5.1 Muscle Spasms
13.5.2 Nausea (from cancer chemotherapy)
13.5.3 Chronic Illness (HIV/Nerve Pain)
13.5.4 Seizure Disorders
13.5.5 Crohn's Disease
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Medical Marijuana Market Analysis, Insights and Forecast, 2017-2032
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Dried Flower
14.4.2 Oils + Concentrates
14.4.3 Softgel Capsules
14.5 Historic and Forecasted Market Size By Application
14.5.1 Muscle Spasms
14.5.2 Nausea (from cancer chemotherapy)
14.5.3 Chronic Illness (HIV/Nerve Pain)
14.5.4 Seizure Disorders
14.5.5 Crohn's Disease
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Medical Marijuana Scope:
|
Report Data
|
Medical Marijuana Market
|
|
Medical Marijuana Market Size in 2025
|
USD XX million
|
|
Medical Marijuana CAGR 2025 - 2032
|
XX%
|
|
Medical Marijuana Base Year
|
2024
|
|
Medical Marijuana Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Scotts Miracle-Gro, Canopy Growth, GW Pharmaceuticals, Aurora Cannabis, Aphria, MedReLeaf, Insys Therapeutics, Sprott, CanniMed Therapeutics, Horizons Marijuana Life Sciences Index ETF.
|
|
Key Segments
|
By Type
Dried Flower
Oils + Concentrates
Softgel Capsules
By Applications
Muscle Spasms
Nausea (from cancer chemotherapy)
Chronic Illness (HIV/Nerve Pain)
Seizure Disorders
Crohn's Disease
|
